iShares Morningstar Large-Cap
Johnson & Johnson’s Revenues Continued to Rise in 1Q18
Johnson & Johnson surpassed Wall Street analysts’ estimates for EPS (or earnings-per-share) and revenues in 1Q18.
Johnson & Johnson’s Growth Rates and Trends in 3Q17
JNJ’s revenues from outside the US markets contribute more than 47% of total revenues for the company.
What Are Eli Lilly’s 4Q16 Expectations for New Products?
Eli Lilly (LLY) has launched various products in various franchises including Taltz, Portrazza, Cyramza, Basaglar, Jardiance, and Trulicity.
A Deeper Look into Eli Lilly’s New Products Portfolio
Eli Lilly has launched various new products under different franchises, including Portrazza, Cyramza, Basaglar, Jardiance, Taltz, and Trulicity.
Eli Lilly and Co.’s 3Q16 Estimates: Expectations for New Products
Eli Lilly and Co. (LLY) has launched various products under different franchises. A few of the new products include Portrazza, Cyramza, Basaglar, Jardiance, and Trulicity.
What Fueled Mondelez’s Margin Expansion in Fiscal 2Q16?
For 2Q16, Mondelez’s delivered another strong quarter of margin expansion. The adjusted operating profit margin expanded 210 basis points to 15.2%.
How Is General Mills Trading Compared to Key Moving Averages?
On June 23, General Mills (GIS) closed at $66.77. It’s trading 8.2% above its 100-day moving average, 5.5% above its 50-day moving average, and 3.3% above its 20-day moving average.
How Colgate Increased Operating Income in Africa/Eurasia Region
Colgate’s (CL) Africa/Eurasia segment’s net revenue decreased 9.1% to $0.2 billion in 1Q16.
Nonalcoholic Beverage Companies Increase Their Marketing Efforts
Nonalcoholic beverage companies continue to spend substantial amounts on the advertising of their products to revive the sales of soda beverages.
Colgate’s Africa Segment Saw Its Net Revenue Fall 16.4% in 4Q15
Colgate’s (CL) Africa/Eurasia segment’s net revenue fell 16.4% to $0.2 billion in 4Q15.
Investor Expectations for Procter & Gamble’s Fiscal 2Q16 Earnings
The Wall Street consensus analyst estimate for adjusted earnings per share in fiscal 2Q16 is $0.98. The estimate represents a 13.7% fall year-over-year compared to fiscal 2Q15.